Fundraising Fox

Biotech Series C Investors & VC Firms

600 firms in this list, with a median first check of $1M. 112 of them lead rounds. Generated from verified public data and updated continuously.

Bain Capital Venture
BostonPre-Seed–Late Stage
43 people
Legend Capital
BeijingPre-Seed–Growth$2.9M – $156M
25 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
39 people
Blue Venture Funds
ChicagoSeed–Late Stage$1M – $20M
25 people
B4 Capital
Pre-Seed–Late Stage$10M – $50M
VantagePoint Capital Partners
Silicon ValleySeed–Late Stage$2M – $100M
21 people
Casdin Capital
New YorkSeed–Series C
39 people
M Ventures
Los AngelesSeed–Growth$10.8M
9 people
Cross Creek Advisors
Salt Lake CitySeries B–Late Stage
19 people
Kyoto University Innovation Capital
KyotoPre-Seed–Growth
20 people
Primo Ventures
MilanPre-Seed–Growth$1.1M
18 people
Innovation Industries
AmsterdamSeed–Late Stage$2.2M – $54M
25 people
Kreos Capital
LondonSeries A–Late Stage
43 people
Ysios Capital
BarcelonaSeries A–Late Stage$5.4M – $21.6M
26 people
Artis Ventures
San FranciscoSeed–Late Stage$50K – $25M
7 people
Abingworth
LondonPre-Seed–Late Stage$15M – $30M
39 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Late Stage
30 people
Agent Capital
WalthamPre-Seed–Late Stage
22 people
Fortune Venture Capital
ShenzhenSeed–Late Stage$425K – $73M
11 people
UntroD Capital
TokyoPre-Seed–Growth$772K – $241M
5 people
Medicxi
LondonPre-Seed–Late Stage
34 people
S32
Palo AltoSeries A–Late Stage
25 people
HealthCap
StockholmSeed–Growth
30 people
GroveStreet
NewtonSeries A–Late Stage
39 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.